FGF-1 and FGF-2 potently induce proliferation and migration of these cells as well as angiogenesis, events that are required during normal embryogenesis and tissue repair. Although expression of FGF-1 and FGF-2 at sites of injury is therefore beneficial, some evidence suggests these growth factors may also contribute to vascular pathology by promoting excessive intimal hyperplasia (2-5). FGF-1 expression is increased at several sites of chronic immune injury, including the synovium in rheumatoid arthritis (6 -8), the myocardium in human hearts after transplantation (9 -11), and in transplanted kidneys undergoing chronic rejection (12, 13). The pathologic lesions in these sites demonstrate cellular responses typical of FGF effects on mesenchymal cells that result in vascular intimal hyperplasia, increased extracellular matrix deposition, and neoangiogenesis. In addition, these sites are characterized by chronic infiltration of T lymphocytes, suggesting there may be interactions between the immune system and fibroblast growth factors as demonstrated by the finding that T cells can produce FGF-2 (14, 15). Evidence that FGFs may have immunoregulatory effects on T cells was first provided in 1985 by Johnson and Torres (16), who showed that FGF, at physiologically relevant concentrations, could replace the requirement for IL-2 or helper cells in production of interferon-␥. Although FGF could activate intracellular signals necessary for interferon-␥ production, FGF alone could not stimulate proliferation of T cells. More recent studies show directly that some human T cells express receptors for FGF-1 and that the normally small subpopulation of FGF-responsive T cells is expanded in the peripheral blood of patients with rheumatoid arthritis and in patients after heart transplantation (8, 17). These data suggest that T cells bearing FGF receptors can be stimulated and expanded in the FGF-enriched environment at sites of immune injury and subsequently migrate to the peripheral blood. As found in the earlier studies (16), FGF alone does not stimulate proliferation of T cells but together with engagement of the T cell antigen receptor induces production of IL-2 and proliferation (17). In T cells, FGF thus functions in a manner analogous to other well described "costimulators" (18,19) to activate a second signal transduction pathway necessary for T cell proliferation and effector function.These findings suggest that FGF and FGF receptors in T cells may function quite differently than in cells in which FGF alone can stimulate proliferation, migration, and secretion of effector molecules such as plasminogen activator (20). Our efforts to investigate T cells that express FGF receptors and the mechanisms by which FGF signals in T cells have been hampered by the lack of reagents that can conveniently identify these cells and allow us to examine the fate of FGF and its receptors in T cells. To address this difficulty, the experiments reported here describe the production and characterization of a fusion protein that includes a por...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.